Clinical trials
Phase 2 Neoplasm Metastasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,013 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 10 |
| 2002 | 20 |
| 2003 | 29 |
| 2004 | 26 |
| 2005 | 45 |
| 2006 | 51 |
| 2007 | 58 |
| 2008 | 31 |
| 2009 | 49 |
| 2010 | 40 |
| 2011 | 47 |
| 2012 | 38 |
| 2013 | 51 |
| 2014 | 46 |
| 2015 | 22 |
| 2016 | 36 |
| 2017 | 35 |
| 2018 | 33 |
| 2019 | 42 |
| 2020 | 38 |
| 2021 | 48 |
| 2022 | 29 |
| 2023 | 29 |
| 2024 | 35 |
| 2025 | 27 |
| 2026 | 51 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 477 |
| Terminated | 183 |
| Unknown status | 99 |
| Recruiting | 88 |
| Active, not recruiting | 65 |
| Withdrawn | 63 |
| Not yet recruiting | 34 |
| Suspended | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 41 |
| National Cancer Institute (NCI) | 29 |
| UNICANCER | 18 |
| Amgen | 16 |
| Memorial Sloan Kettering Cancer Center | 16 |
| H. Lee Moffitt Cancer Center and Research Institute | 14 |
| Eli Lilly and Company | 13 |
| AstraZeneca | 12 |
| Dana-Farber Cancer Institute | 12 |
| Fudan University | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 1,013 |
| Neoplasms | 154 |
| Breast Neoplasms | 150 |
| Colorectal Neoplasms | 126 |
| Recurrence | 83 |
| Carcinoma, Non-Small-Cell Lung | 73 |
| Prostatic Neoplasms | 64 |
| Carcinoma, Renal Cell | 60 |
| Melanoma | 60 |
| Lung Neoplasms | 51 |
Trials
Showing 26 to 50 of 1,013. Each trial links to its page on Pharma Observatory.
913 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.